Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
In Vivo (Athens, Greece)|July 8, 2019
Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in JapanIsao Yoshida, Kazuo Tamura, Toshihiro Miyamoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 14, 2015
[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]Seiichiro Katagiri, Tetsuzo Tauchi, Tomohiro Umezu, et al.
Hematological Oncology|December 9, 2015
The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDSShinichi Kako, Yoshinobu Kanda, Jun Kato, et al.
Leukemia & Lymphoma|November 28, 2018
BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphomaYoshikazu Ito, Tomohiro Umezu, Kenichi Tadokoro, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2025
[Comparison of IPSS-R and IPSS-M in newly diagnosed myelodysplastic neoplasms: a single-center study]Shunsuke Otsuki, Seiichiro Katagiri, Yuya Arai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2020
D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority TrialYoshinobu Kanda, Shun-Ichi Kimura, Masaki Iino, et al.
Pageof 4